Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma

Semaglutide could regulate the development of KIRC by up-adjusting the expression of Man1a1 and Ntn4.

Authors

Institutions

Publication Details

Journal
Diabetes Metabolic Syndrome and Obesity
Published
2025-03-01
DOI
https://doi.org/10.2147/dmso.s498447
Citations
2
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma

Xiaoman Yang, Shuqi Wang, Mengmeng Zhang, Shuchun Chen
2 citations
Diabetes Metabolic Syndrome and Obesity
Renal cell carcinoma treatment
3.04
article

Protective Effect of Semaglutide on Obesity-Induced Renal Disease and Obesity-Induced Kidney Renal Clear Cell Carcinoma

Xiaoman Yang, Shuqi Wang, Mengmeng Zhang, Shuchun Chen
article en
2 citations

Abstract

Semaglutide could regulate the development of KIRC by up-adjusting the expression of Man1a1 and Ntn4.

Diabetes Metabolic Syndrome and ObesityVol. Volume 18
Hebei Medical University (CN), Hospital of Hebei Province (CN), Hebei General Hospital (CN)
Openalex Percentile: Top 10%
Renal cell carcinoma treatment
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.